Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation

Yahoo FinanceJan 5 08:16 ET

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development

AccesswireDec 19, 2024 09:00 ET

Express News | Mira Pharmaceuticals Inc - Submits Ind Application to FDA for Ketamir-2

ReutersDec 19, 2024 08:34 ET

Express News | Mira Pharmaceuticals Inc: Submission of Investigational New Drug (Ind) Application by End of 2024

ReutersDec 10, 2024 08:47 ET

Express News | EXCLUSIVE: Mira Pharmaceuticals Tells Benzinga 'Advancing Ketamir-2 Into Clinical Trials as Quickly as Possible Reflects Our Strategic Focus on Generating Proof-of-concept Data That Positions MIRA for a Potential M&A Transaction or Strategic Partnership'

BenzingaDec 10, 2024 08:15 ET

EXCLUSIVE: MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile, Paving Way For Human Trials In Neuropathic Pain

BenzingaDec 10, 2024 08:15 ET